In a 10‑month‑old infant with paroxysmal nighttime cough, thick nasal secretions, and post‑tussive vomiting but without a classic inspiratory whoop, what is the recommended management?

Management of Suspected Pertussis Without Classic Whoop

Treat this 10-month-old infant empirically for pertussis with azithromycin even without the classic inspiratory whoop, as the absence of whoop does not exclude pertussis—particularly in infants and previously vaccinated children—and the clinical presentation of paroxysmal nighttime cough with post-tussive vomiting is highly suggestive. 1

Why the Whoop Doesn't Matter

The classic inspiratory "whoop" is frequently absent in infants, previously vaccinated children, and adults with pertussis 1, 2. Your 10-month-old patient falls into this category. The disease presents insidiously with catarrhal symptoms (nasal congestion, runny nose, mild cough) that are indistinguishable from minor respiratory infections, then progresses to the paroxysmal stage 1. The key diagnostic features you should focus on are:

• Paroxysmal coughing (succession of coughs without inspiration between them)
• Post-tussive vomiting
• Nighttime predominance of coughing episodes
• Thick nasal secretions during catarrhal phase
• Patient appears relatively well between episodes

All of these features are present in your patient and constitute a clinical diagnosis of pertussis regardless of whoop presence 1, 2.

Immediate Treatment Protocol

For This 10-Month-Old Infant:

Azithromycin is the first-line agent 1:

• 10 mg/kg on day 1 (maximum 500 mg)
• 5 mg/kg daily on days 2-5 (maximum 250 mg per day)

This regimen is preferred over erythromycin because it:

• Requires only once-daily dosing (better adherence)
• Has fewer gastrointestinal side effects
• Lacks the cytochrome P450 interactions seen with erythromycin and clarithromycin
• Does not carry the infantile hypertrophic pyloric stenosis (IHPS) risk associated with erythromycin in young infants 1

Alternative if Macrolide Allergy or Resistance:

Trimethoprim-sulfamethoxazole (TMP-SMZ) can be used as an alternative in infants >2 months old 1, 3. However, given emerging erythromycin-resistant Bordetella pertussis (ERBP) reported particularly in China 3, if the patient fails to improve on azithromycin or if local resistance patterns suggest ERBP, consider TMP-SMZ as second-line therapy.

Critical Timing Considerations

Antibiotics are most effective when started during the catarrhal stage or within the first 3 weeks of cough onset 1. While they may not dramatically alter the clinical course once paroxysms are established, they are essential for:

1. Eradicating nasopharyngeal carriage (reducing infectiousness from >80% secondary attack rate) 1
2. Preventing transmission to vulnerable contacts, especially infants <12 months 1
3. Potentially shortening symptom duration if given early 1

Patients are most infectious during the catarrhal stage and first 3 weeks after cough onset 1.

Household Contact Management

All close household contacts require postexposure prophylaxis with the same antibiotic regimen (azithromycin at treatment doses) within 21 days of the index patient's cough onset 1. This is non-negotiable if there are:

• Infants <12 months in the household
• Pregnant women in third trimester
• Any incompletely vaccinated children

Symptomatic household contacts should be treated as cases, not just given prophylaxis 1.

Diagnostic Confirmation

While you should not delay treatment waiting for test results, obtain:

• Nasopharyngeal swab for PCR (most sensitive, especially after 3 weeks of symptoms) 4, 5
• Culture (if <3-4 weeks from cough onset, though less sensitive than PCR) 1

Do not rely on serologic testing—it is not standardized or routinely recommended 2.

Expect laboratory findings of leukocytosis with marked lymphocytosis (though this can be absent or atypical) 4, 6.

Red Flags Requiring Hospitalization

Monitor closely for severe pertussis complications, particularly in infants <12 months 1, 7:

• Apneic episodes (can be the initial presentation in young infants)
• Cyanosis or significant respiratory distress
• Post-tussive vomiting leading to dehydration
• Pneumonia (primary or secondary bacterial)
• Extreme leukocytosis (>50 × 10⁹/L suggests malignant pertussis with risk of pulmonary hypertension) 6

Infants <4 months have the highest risk for severe, life-threatening complications and often require hospitalization 1.

Common Pitfalls to Avoid

1. Waiting for the whoop: The whoop is often absent in infants and vaccinated children—don't let this delay diagnosis 1, 2

2. Dismissing as viral URI: The catarrhal stage is indistinguishable from common colds; maintain high suspicion if cough becomes paroxysmal 1, 7, 5

3. Delaying household prophylaxis: Secondary attack rates exceed 80% in susceptible contacts; prophylaxis must be given promptly 1

4. Using erythromycin in young infants: Azithromycin is preferred in infants <1 month due to IHPS risk with erythromycin 1

5. Expecting antibiotics to stop the cough immediately: Once paroxysms are established, the cough can persist for weeks despite appropriate treatment; the goal is to prevent transmission 1